Related Experiment Video
Updated: Nov 1, 2025

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
Published on: September 2, 2022
Efficient antigen cross-presentation through coating conventional aluminum adjuvant particles with PEI
Hongyan Ren1,2, Yongbin Mou2,3, Lin Lin2,4
1Department of Pathology and Pathophysiology, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine Nanjing 210023, P. R. China.
Coating aluminum adjuvants with polyethyleneimine (PEI) enhances antigen cross-presentation by dendritic cells (DCs). This improvement in antigen delivery boosts CD8+ T cell responses, offering a promising strategy for vaccine development.
Area of Science:
- Immunology
- Nanotechnology
- Vaccine Adjuvants
Background:
- Classical aluminum adjuvants are suboptimal carriers for antigen cross-presentation and CD8+ cytotoxic T cell priming.
- Covalent conjugation of antigens to α-Al2O3 nanoparticles previously enhanced cross-presentation efficiency.
Purpose of the Study:
- To investigate the effect of coating aluminum adjuvants with polyethyleneimine (PEI) on antigen cross-presentation.
- To evaluate the in vitro and in vivo efficacy of PEI-coated aluminum adjuvants in enhancing dendritic cell (DC) function.
Main Methods:
- Coating conventional aluminum adjuvants with polyethyleneimine (PEI).
- Assessing antigen cross-presentation by dendritic cells (DCs) in vitro.
- Evaluating the in vivo immune response following administration of PEI-coated adjuvants.
Main Results:
- Coating aluminum adjuvants with PEI significantly enhanced antigen cross-presentation by DCs.
- PEI demonstrated differential effects on the efficiency of antigen cross-presentation.
- The PEI-coated adjuvants showed improved performance both in vitro and in vivo.
Conclusions:
- Polyethyleneimine coating represents a viable strategy to improve the antigen-carrying capacity of aluminum adjuvants.
- This approach enhances DC-mediated antigen cross-presentation, crucial for effective CD8+ T cell responses.
- Findings support the rapid clinical translation of modified alumina nanoparticle adjuvants for vaccine applications.
More Related Videos
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
10:16Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
Published on: October 12, 2018
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Cross-reactivity